This protocol details a method of obtaining selectively proliferated hepatocyte progenitor cells using hyaluronic acid (HA)-coated dishes and serum-free medium. A small hepatocyte (SH) is a hepatocyte progenitor cell of adult livers and has many hepatic functions. When the rat SH begins to proliferate, CD44 is specifically expressed. To define the purification of SH, CD44 and cytokeratin 8 are used as marker proteins. The growth of SHs is faster on HA-coated dishes than on other extracellular matrix-coated ones. The use of both DMEM/F12 medium and HA-coated dishes allows the selective proliferation of SHs in culture. The purification of SHs is approximately 85% at day 10.
INTRODUCTION
Small hepatocytes (SHs) are a subpopulation of hepatocytes that have high growth potential in culture 1 . Although the cells are less than half the size of mature hepatocytes (MHs), they possess hepatic characteristics 1 . SHs can clonally proliferate to form a colony and can differentiate into MHs by interacting with hepatic non-parenchymal cells (NPCs) 2, 3 or as a result of treatment with gel derived from Engelbreth-Holm-Swarm sarcoma 4 . Thus, we consider that SHs may be 'committed progenitor cells' that can further differentiate into MHs. The standard method to obtain an SH-rich fraction, which is a mixture of SHs and NPCs from a liver cell suspension after collagenase perfusion, has used multistep centrifugation. However, with this method, although SHs account for more than 60% of the cells at day 10, it is very difficult to inhibit the growth of NPCs.
Recently, gene expression analysis revealed that CD44 is specifically expressed in SHs but not in MHs 5 . The CD44 gene encodes for a family of alternatively spliced multifunctional molecules, and CD44 plays a role in adhesion of cells to an extracellular matrix such as hyaluronic acid (HA), collagen (Col) or fibronectin (FN) 6 . CD44 standard form (CD44s) is composed of a short cytoplasmic tail, a transmembrane region and two extracellular domains, and ten variant forms (v1-v10) exist. SHs have been shown to express CD44s and v6 (ref. 5 ). CD44s in SHs appears from 3 d after plating; expression increases with the expansion of the SH colony, but decreases with the maturation of SHs. The appearance of CD44v6 is delayed compared with that of CD44s. The expression also disappears with maturation of SHs. Although CD44 is expressed in cultured SHs, no CD44 + hepatocytes are found in the normal rat liver. When the rat liver is severely injured by hepatotoxins such as galactosamine and 2-acetylaminofluorene, CD44 + hepatocytes transiently appear in the periportal regions of the liver lobules. Using an anti-CD44 Ab, we have isolated CD44 + cells from the galactosaminetreated rat liver 5 . These CD44 + cells possess the characteristics of SHs. However, as we were not able to isolate CD44 + SHs from either a normal adult liver or from a liver with two-thirds removed, we tested HA as a ligand for separating a population of SHs.
HA, a linear polymer of (1-b-4)-D-glucuronic acid (1-b-3)-Nacetyl-D-glucosamine, is a large glycosaminoglycan that can reach a molecular size of 10 7 Da. It is found in the tissue matrix and body fluids of all vertebrates and has diverse biological roles. These include acting as a vital structural component of connective tissues and playing roles in the formation of loose hydrated matrices that allow cells to divide and migrate, immune cell adhesion and activation, and intracellular signaling 7 . Such diversity results from the large number of hyaluronan-binding proteins (termed hyaladherins), which exhibit significant differences in their tissue expression, cellular localization, specificity, affinity and regulation. Three HA synthase (HAS) genes, coding for HAS-1, 2 and 3, are recognized to synthesize HA 8 . HAS is located at the inner cell membrane, where the newly synthesized HA is extruded into the extracellular space 9 . Synthesized HA is degraded locally in the tissues where it is produced or by the lymph nodes, and the reminder enters the bloodstream 10 . More than 90% of circulating HA is degraded by hepatic sinusoidal endothelial cells (SECs) through a receptor recycling pathway. Hyaladherins, LYVE-1 and stabilin-1 and 2, but not CD44, are expressed in SEC 11, 12 . Furthermore, a relationship between serum HA levels and liver diseases has been reported 13 . HA may be related to the induction of SHs in the liver.
We found that SHs cultured on HA-coated dishes could selectively proliferate to form colonies and that the contamination by NPCs with this method was much less than with our previous method. Although we do not know in detail why a population of SHs can be isolated from a normal liver and selectively proliferate on HA-coated dishes, the HA-CD44 interaction may enhance the growth of SHs. In addition, the combination of DMEM/F12 medium and HA-coated dishes allows us to exclude FBS from the culture. Using this protocol, we have isolated human SHs from a normal adult liver. Taking into consideration the application of hepatic stem/progenitor cells to regenerative medicine, the use of proteins derived from an animal, particularly FBS, should be avoided in the culture of the cells. This protocol for isolating and culturing SHs may help researchers in this field to progress in their own investigations. . Ascorbic acid-2 phosphate (Asc2P; Wako Pure Chemical Industries, Osaka, Japan, cat. no. 013-12061) (see REAGENT SETUP) . BSA 2 O into a 1,000-ml graduated cylinder; add 100 ml 10Â Ca 2+ , Mg 2+ -free HANKS, 190 mg EGTA, 1 ml 1,000Â insulin stock solution and stir and adjust pH to 7.5 with 7 ml 1 M NaHCO 3 . Adjust to 1,000 ml and filter with a 0.2-mm filter. Distribute into each bottle (150 ml). Store at 4 1C until use. m CRITICAL EGTA solution should be warmed to 37 1C before use. Perfusion solution To 200 ml HANKS, add 1 ml 1,000Â insulin stock solution and collagenase (100 U ml À1 ). Shake gently. m CRITICAL Prepare HANKS with insulin before the experiment. Add collagenase to pre-warmed perfusion solution just before use and immediately dissolve by gentle shaking. Wash solution To 500 ml HANKS, add 0.5 ml 1,000Â insulin stock solution, 2 ml penicillin-streptomycin solution and 0.5 ml gentamicin solution. MH wash solution To 500 ml HANKS, add 0.5 ml 1,000Â insulin stock solution, 3.3 ml BSA, 2 ml penicillin-streptomycin solution and 0.5 ml gentamicin solution. Percoll solution 15 Add 2.4 ml 10Â HANKS and 21.6 ml Percoll into a 50-ml conical tube. Mix gently upside down several times. Store at 4 1C until use. Trypan blue stock solution (0.1%) Add 100 mg trypan blue to 100 ml phenol red-free HANKS. Filter with a paper filter. Dexamethasone stock solution Add 39.2 mg dexamethasone to an autoclaved brown bottle. Add 10 ml ethanol (10 À2 M stock solution); dilute to 100Â (10 À4 M) with autoclaved ddH 2 O. Store at 4 1C until use. m CRITICAL 10 À4 M stock solution must be used within 3 months. EGF stock solution (10 lg ml À1 ) Add 10 ml autoclaved ddH 2 O to an EGF vial. Store 1-ml aliquots in microcentrifuge tubes at À20 1C until use. Nicotinamide stock solution (1M) Add 12.21 g nicotinamide to 100 ml PBS. Filter with a 0.2-mm filter and store at 4 1C until use. Asc2P stock solution (100 mM) Add 2.90 g Asc2P to 100 ml PBS, filter with a 0.22-mm filter and store at 4 1C in a 100-ml brown bottle until use. Culture medium stock Add the following reagents to a 1,000-ml beaker: DMEM/F12 (15.56 g), HEPES (1.20 g), L-Proline (30 mg), penicillin-streptomycin (8 ml), ddH 2 O up to 1,000 ml. Mix using a magnetic stir bar, add 2.20 g NaHCO 3 , adjust pH to 7.6 with 1 N NaOH and filter with a 0.2-mm filter. Store at 4 1C until use. Preparation of culture medium Mix DMEM/F12 stock medium (500 ml), BSA (1.67 ml), nicotinamide stock solution (5.50 ml), Asc2P stock solution (5 ml), ITS (5 ml), EGF stock solution (0.5 ml), dexamethasone stock solution (0.5 ml) and gentamicin (0.5 ml). EQUIPMENT SETUP Perfusion system See Figure 1a . The system is composed of a water bath, vascular clamp, peristatic pump, silicon tube (f4.76 Â 7.94 mm 2 ) and 18-gauge butterfly needle.
PROCEDURE
Preparation of HA-coated dishes TIMING At least 1 d before the experiment 1| Dilute the stock HA solution to 100 mg cm À2 with PBS, fill Petri dishes and incubate at 37 1C overnight. The next day, discard the solution and wash once with PBS. Aspirate PBS and leave to dry on a clean bench with UV irradiation for 30 min. ! CAUTION UV is harmful to skin and eyes. ? TROUBLESHOOTING Isolation of liver cells TIMING 1-1.5 h 2| Settle the perfusion apparatus in the warmed water bath (Fig. 1a) . Pour the pre-perfusion solution into the apparatus before the experiment and bubble it with 95% O 2 /5% CO 2 gas at a flow rate of 0.5 l min À1 . 5| Ligate a common bile duct and splenic vein together using a surgical thread at the portion nearest the portal vein (Fig. 1b) . m CRITICAL STEP This is to avoid loss of the solution.
? TROUBLESHOOTING 6| Insert a butterfly needle filled with pre-perfusion solution into the portal vein 1.5-2.0 cm from the bifurcation of the portal vein, stop the tip of the needle at a position close to the bifurcation of the portal vein and clamp the needle with a surgical clip (Fig. 1b) . ? TROUBLESHOOTING 7| Start the perfusion at a flow rate of 30 ml min À1 .
8| Cut the inferior vena cava and heart as soon as the flow starts. m CRITICAL STEP Cut the inferior vena cava at the portion beneath the right kidney and the thoracic cavity, and then cut the heart to flow the perfusate out of the cadaver. Washing out the blood completely from the liver and preventing an increase of intra-hepatic pressure is important to the success of the preparation. ? TROUBLESHOOTING 9| When the amount of the pre-perfusion solution becomes small, add collagenase to the perfusion solution and then pour it into the perfusion apparatus. m CRITICAL STEP To avoid a decrease in collagenase activity, dissolve it after the pre-perfusion solution flows. Do not mix vigorously. ? TROUBLESHOOTING 10| Flow the solution at a flow rate 15-20 ml min À1 . m CRITICAL STEP The flow rate should be decided by rat body weight. ? TROUBLESHOOTING 11| Stop the flow before air bubbles move into the liver when the solution flows out from the reservoir. ? TROUBLESHOOTING 12| Cut the liver from the abdominal cavity and transfer it to a sterilized Petri dish.
13| Prepare a 100-ml beaker with 70-80 ml wash solution and add a small amount of the wash solution to the Petri dish. m CRITICAL STEP From this step onward, all procedures should be done in sterilized conditions. 14| Peel the hepatic capsule as carefully as possible and, to drop the digested cells, shake the liver into the beaker. ? TROUBLESHOOTING 15| Filter the cell suspension through a 250-mm nylon filter net into a new 100-ml beaker.
16| Filter the cell suspension through a 70-mm filter into four 50-ml conical tubes using a 25-ml pipette and then adjust each tube to an equal volume with the wash solution (approximately 40 ml). ?
? TROUBLESHOOTING (viii) Add 10 ml culture medium to each tube and gather the suspension into one tube.
(ix) Add 0.5 ml cell suspension to 1.5 ml trypan blue solution and pipette gently. m CRITICAL STEP Tubes should be on ice. ? TROUBLESHOOTING (xii) Place dishes in a 5% CO 2 /95% air incubator at 37 1C. ? TROUBLESHOOTING (xvii) Place the dishes in a 5% CO 2 /95% air-incubator at 37 1C.
(xviii) 1-2 h later, replace the medium with fresh medium. m CRITICAL STEP If researchers need to grow MHs, we suggest using nicotinamide-supplemented medium 1 (ii) Although collagenase works efficiently at a slow flow rate, too slow a flow causes partial perfusion of the liver, and the yield and viability of the cells have a tendency to be bad
Flow rate
The flow rate depends on the weight of the rat. When the weight is more than 250 g, use the maximum flow rate of 20 ml min À1 . Liver weight is not correlated to body weight in bigger rats. A relatively high flow rate may cause the early rupture of hepatic capsules Embolisms (i) Inside of the needle is not filled with perfusate (ii) Do not shake vigorously after collagenase is added to perfusion solution (iii) Tube sometimes generates bubbles and causes air embolisms in the liver. An air-trap apparatus is necessary. A rapid change of liver color from red-brown to light brown is a sign of good circulation of the perfusate. Red spots in the liver may result from embolisms
Step 14 Step 19A(xi) Poor growth of SHs Few SH colonies (i) Avoid plating too small a number of cells. We found that fewer than 2.5 Â 10 3 cells cm À2 resulted in a smaller number of SH colonies than we expected (ii) Total number of SH colonies is dependent on rats. Cells from younger rats make many colonies per dish 19 Step 19B(viii) No pellet Poor mixture Mix the cell suspension again and repeat Step 8. Good mixing of cells and Percoll solution is important to obtain high viability and purity of mature hepatocytes (MHs)
Step Step Problem Possible reason Solution
ANTICIPATED RESULTS
A critical component of this method is to use HA-coated dishes and serum-free medium for SH culture. As CD44 is not expressed in MHs but is expressed in SHs, we first examined whether SHs could selectively proliferate on HA-coated dishes under our standard culture conditions (DMEM + 10% FBS). As shown in Figure 2a , compared with the NC-, non-, rat tail Col-and FN-coated dishes, SHs could selectively proliferate on HA-coated dishes. However, there was much less growth of NPCs in HA-coated dishes than in other dishes. The average size of SH colonies on HA-coated dishes was larger than that of SH colonies on NC-, Col-and FN-coated dishes (Fig. 2b) . Although the SH growth on non-coated dishes was as good as that on HA-coated dishes, NPCs also grew ( Table 2) . Next, we examined whether SHs could proliferate in serum-free medium. Although we reported that SH colonies could expand in serumfree medium after re-plating SH colonies 4, 16 , it was very difficult for SHs in serum-free medium to grow to form colonies on conventional dishes. When we used serum-free DMEM/F12 and HA-coated dishes, many colonies developed (Fig. 3a) , whereas few colonies grew in serum-free DMEM (Fig. 3b) . We usually use HA derived from human umbilical cords. However, the effect of HA is not different among commercially available forms of HA derived from pig skin, bovine vitreous humor, rooster comb and Streptococcus (data not shown). To observe the appearance of SHs in serum-free culture, both nicotinamide and growth factors (either a single factor or a combination of EGF, hepatocyte growth factor and transforming growth factor-a) must be included in the medium 1 . These results suggest that ingredients contained in Ham F12 medium are important for SHs to grow in the serum-free culture, because the use of DMEM alone without FBS cannot support the growth of SHs. However, when the specific agents included in Ham F12 medium were added to DMEM and SHs were cultured in the serum-free medium, the growth of SHs was neither enhanced nor inhibited (data not shown). Therefore, we now hypothesize that the balance of ingredients in Ham F12 medium may be important for SHs to grow in serum-free culture. On the other hand, adding transferrin and selenium is different from the original recipe for culturing rat SHs 2 . Although SHs appear and grow without those agents, both are necessary to maintain their growth in serum-free culture. Without transferrin and selenium, the growth of SHs becomes worse after 1-2 weeks of culture (current data not shown; refer to ref. 1). Figure 3a shows a typical SH colony in serum-free culture. Although it was difficult to avoid MH survival in DMEM with FBS, the use of HA-coated dishes and serum-free medium suppressed MH survival. Most attached MHs died within 1 week (Fig. 3c) . In this protocol, the purity of SHs was 84.5% ± 3.2% at day 10 ( Table 2) . Some SECs (SE1 + ), stellate cells (desmin + ), liver epithelial cells (vimentin + ) and Kupffer cells (ED1/2 + ) were observed. Characterization of SHs on HA was carried out using immunocytochemistry and RT-PCR. All SHs were immunocytochemically stained with anti-CD44 (Fig. 4a) and anti-CK8 Abs (Fig. 4b) . As shown in Figure 4c , RT-PCR shows that SHs express mRNAs of hepatic marker genes such as albumin, transferrin, tyrosine aminotransferase, hepatocyte nuclear factor-4a and CK8 as plentifully as MHs at day 10. In addition, CD44 is not expressed in MHs but is expressed in SHs. These results reveal that cell colonies grown in serum-free DMEM/F12 on HA have quite similar characteristics to SHs observed using our standard culture method (DMEM/FBS). Until now, we have not observed any difference between the cells.
The SH is a hepatocyte progenitor cell that is committed to differentiate into an MH. Manipulation of the growth and maturation of SHs is easy, and they can be cryopreserved 17 . Cryopreserved SHs can maintain the abilities of growth and maturation 18 . Maturated SHs in serum-free culture can be used for studies of hepatic drug metabolism, liver diseases and regenerative medicine. 
